World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
95
Citations
35107
World Ranking
10020
National Ranking
5158

Paul Martin publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Paul Martin sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 537 publications — 64th percentile

64% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Paul Martin D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Paul Martin sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 95 D-Index — 51st percentile

51% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Paul Martin is affiliated with the University of Miami in the United States and has contributed extensively to medical research, particularly in gastroenterology and related fields. Their scholarly output spans over 300 publications, with a strong focus on medicine and biochemistry, genetics, and molecular biology.

The scientist's main fields of study include:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

Paul Martin's research further delves into specialized subfields, notably:

  • Surgery
  • Genetics
  • Gastroenterology
  • Epidemiology
  • Molecular Biology

Their work prominently addresses several key topics in gastroenterological and immunological research including:

  • Inflammatory Bowel Disease
  • Microscopic Colitis
  • Helicobacter pylori-related gastroenterology studies
  • Gut microbiota and health
  • Gastrointestinal motility and disorders
  • Gastric Cancer Management and Outcomes
  • Eosinophilic Esophagitis

Paul Martin's recent papers exemplify the scope and focus areas of their research, with significant contributions to high-impact journals:

  • Helicobacter pylorieradication therapy to prevent gastric cancer: systematic review and meta-analysis, 2020, published in Gut
  • Association of ultra-processed food intake with risk of inflammatory bowel disease: prospective cohort study, 2021, published in BMJ
  • Increased Intestinal Permeability Is Associated With Later Development of Crohn's Disease, 2020, published in Gastroenterology
  • Efficacy of psychological therapies for irritable bowel syndrome: systematic review and network meta-analysis, 2020, published in Gut
  • Novel Fecal Biomarkers That Precede Clinical Diagnosis of Ulcerative Colitis, 2020, published in Gastroenterology

The most common publication venues for their research include:

  • Gastroenterology
  • Journal of the Canadian Association of Gastroenterology
  • Journal of Crohn's and Colitis
  • Alimentary Pharmacology & Therapeutics
  • The American Journal of Gastroenterology

Paul Martin collaborates frequently with several notable researchers in their field. The most frequent co-authors are:

  • Kenneth Croitoru
  • John K. Marshall
  • Williams Turpin
  • Kevan Jacobson
  • Çharles N. Bernstein

Best Publications

  • Results of a Prospective Study of Acute Liver Failure at 17 Tertiary Care Centers in the United States

    George Ostapowicz;Robert J. Fontana;Frank V. Schioødt;Anne Larson

  • Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial.

    A. M. Di Bisceglie;P. Martin;C. Kassianides;M. Lisker-Melman

  • Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation

    Paul Martin;Andrea DiMartini;Sandy Feng;Robert Brown

  • Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B.

    Marion G. Peters;H. W. Hann;Paul Martin;E. Jenny Heathcote

  • Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4-5 chronic kidney disease (the C-SURFER study): a combination phase 3 study.

    David Roth;David R. Nelson;Annette Bruchfeld;Annmarie Liapakis

  • A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States: 2008 Update

    Emmet B. Keeffe;Douglas T. Dieterich;Steven Huy B. Han;Ira M. Jacobson

  • Entecavir for treatment of lamivudine-refractory, HBeAg-positive chronic hepatitis B.

    Morris Sherman;Cihan Yurdaydin;Jose Sollano;Marcelo Silva

  • Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin.

    Jay S. Markowitz;Paul Martin;Andrew J. Conrad;James F. Markmann

  • Hepatitis C infection and the patient with end‐stage renal disease

    Fabrizio Fabrizi;F. Fred Poordad;Paul Martin

  • A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis B.

    Robert P. Perrillo;Teresa Wright;Jorge Rakela;Gary Levy

  • A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States: An Update

    Emmet B. Keeffe;Douglas T. Dieterich;Steven–Huy B. Han;Ira M. Jacobson

  • A treatment algorithm for the management of chronic hepatitis B virus infection in the United States.

    Emmet B. Keeffe;Douglas T. Dieterich;Steve Huy B. Han;Ira M. Jacobson

  • The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease.

    Kenneth R. Cooke;Leo Luznik;Stefanie Sarantopoulos;Frances T. Hakim

  • Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience.

    John A. Goss;Christopher R. Shackleton;Douglas G. Farmer;Walid S. Arnaout

  • Peginterferon alfa-2a for hepatitis C after liver transplantation: Two randomized, controlled trials†

    Naga Chalasani;Cosme Manzarbeitia;Peter Ferenci;Wolfgang Vogel

  • Multicenter study of lamivudine therapy for hepatitis B after liver transplantation

    Robert Perrillo;Jorge Rakela;Jules Dienstag;Gary Levy

  • Virologic Monitoring of Hepatitis B Virus Therapy in Clinical Trials and Practice: Recommendations for a Standardized Approach

    Jean–Michel Pawlotsky;Jean–Michel Pawlotsky;Geoffrey Dusheiko;Angelos Hatzakis;Daryl Lau

  • Rapidly progressive non-A, non-B hepatitis in patients with human immunodeficiency virus infection

    Paul Martin;Adrian M. Di Bisceglie;Chris Kassianides;Mauricio Lisker-Melman

  • The impact of hepatitis C virus infection on survival in dialysis patients: meta-analysis of observational studies.

    F. Fabrizi;B. Takkouche;G. Lunghi;V. Dixit

  • Crohn’s ileitis after liver transplantation from a living related donor with Crohn’s disease

    K A Papadakis;R Matuk;M T Abreu;E A Vasiliauskas

Frequent Co-Authors

Ronald W. Busuttil
Ronald W. Busuttil University of California, Los Angeles
Douglas G. Farmer
Douglas G. Farmer University of California, Los Angeles
Michel Jadoul
Michel Jadoul Université Catholique de Louvain
Sammy Saab
Sammy Saab University of California, Los Angeles
John A. Goss
John A. Goss Baylor College of Medicine
Eugene R. Schiff
Eugene R. Schiff University of Miami
Fasiha Kanwal
Fasiha Kanwal Baylor College of Medicine
Brennan M.R. Spiegel
Brennan M.R. Spiegel Cedars-Sinai Medical Center
Andreas G. Tzakis
Andreas G. Tzakis Cleveland Clinic
Frederick R. Appelbaum
Frederick R. Appelbaum Fred Hutchinson Cancer Research Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in Medicine opens doors to various allied health pathways that can be pursued online, making education more flexible and accessible. One popular route is enrolling in accelerated healthcare programs, which allow students to fast-track their studies and quickly enter the workforce—ideal for those eager to make an impact sooner.

For registered nurses looking to advance, rn to np programs offer a seamless bridge toward becoming a nurse practitioner. These programs are specifically tailored for RNs seeking greater responsibility, earning potential, and leadership roles in healthcare.

Nutrition is another vital field, with opportunities to help communities achieve better health. An nutrition degree online provides flexibility for those juggling work or family commitments while building expertise in diet and wellness.

Lastly, healthcare administration is critical for those interested in the leadership and management side of medicine. Accredited online mha programs prepare graduates for influential roles across hospitals, clinics, and public health organizations.

Best Scientists Citing Paul Martin

Trending Scientists

Recently Published Articles